Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Pollock

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
American Journal of Physiology. Renal Physiology|November 13, 2004
Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosisW Qi, S Twigg, X Chen, et al.
Pflugers Archiv : European Journal of Physiology|February 7, 1998
Physiological changes in extracellular sodium directly control human proximal tubule growth and transportD W Johnson, H J Saunders, P Poronnik, et al.
Pflugers Archiv : European Journal of Physiology|March 1, 1991
Proximal tubular cell sodium concentration in early diabetic nephropathy assessed by electron microprobe analysisC A Pollock, M J Field, T E Bostrom, et al.
Nephron|December 22, 2000
Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cellsD W Johnson, H J Saunders, D A Vesey, et al.
Medicine|September 1, 1989
Continuous ambulatory peritoneal dialysis. Eight years of experience at a single centerC A Pollock, L S Ibels, R J Caterson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factorD W Johnson, H J Saunders, F J Johnson, et al.
Experimental Nephrology|November 13, 1999
Fibrogenic effects of cyclosporin A on the tubulointerstitium: role of cytokines and growth factorsD W Johnson, H J Saunders, F J Johnson, et al.
Medicine|July 1, 1994
Hyperlipidemia in renal transplant recipients: natural history and response to treatmentC S Ong, C A Pollock, R J Caterson, et al.
Transplantation Proceedings|June 1, 1995
Hyperlipidemia in renal transplant recipients: does it matter and can we treat it?C A Pollock, J F Mahony, C S Ong, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1996
Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patientsL Fung, C A Pollock, R J Caterson, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
American Journal of Physiology. Renal Physiology|November 13, 2004
Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosisW Qi, S Twigg, X Chen, et al.
Pflugers Archiv : European Journal of Physiology|February 7, 1998
Physiological changes in extracellular sodium directly control human proximal tubule growth and transportD W Johnson, H J Saunders, P Poronnik, et al.
Pflugers Archiv : European Journal of Physiology|March 1, 1991
Proximal tubular cell sodium concentration in early diabetic nephropathy assessed by electron microprobe analysisC A Pollock, M J Field, T E Bostrom, et al.
Nephron|December 22, 2000
Enalaprilat directly ameliorates in vitro cyclosporin nephrotoxicity in human tubulo-interstitial cellsD W Johnson, H J Saunders, D A Vesey, et al.
Medicine|September 1, 1989
Continuous ambulatory peritoneal dialysis. Eight years of experience at a single centerC A Pollock, L S Ibels, R J Caterson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: roles of insulin-like growth factor I, transforming growth factor beta1, and platelet-derived growth factorD W Johnson, H J Saunders, F J Johnson, et al.
Experimental Nephrology|November 13, 1999
Fibrogenic effects of cyclosporin A on the tubulointerstitium: role of cytokines and growth factorsD W Johnson, H J Saunders, F J Johnson, et al.
Medicine|July 1, 1994
Hyperlipidemia in renal transplant recipients: natural history and response to treatmentC S Ong, C A Pollock, R J Caterson, et al.
Transplantation Proceedings|June 1, 1995
Hyperlipidemia in renal transplant recipients: does it matter and can we treat it?C A Pollock, J F Mahony, C S Ong, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1996
Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patientsL Fung, C A Pollock, R J Caterson, et al.
Pageof 8